Inscipta Named in Colorado’s Top 10 Tech and Startup Fundings of 2021
By: Colorado BioScience Association Date: 12/23/2021
There have been more than a dozen deals north of $100 million in 2021, including three over $200 million in the technology space.
CBSA member and Boulder-based Inscripta Inc., a digital genome engineering company, closed a $150 million Series E financing round in April. They announced the first commercial shipment of its Onyx platform that allows for scalable digital genome engineering.
In 2020, Inscripta won Company of the Year at the Colorado BioScience Annual Awards Celebration.
Read about Colorado’s Top 10 Tech and Startup Fundings of 2021 in the Denver Business Journal.